# Valid Biomarkers in Blood to Predict the Response to Therapy in Prostate Cancer Patients

> **NCT03408964** · — · RECRUITING · sponsor: **Oncology Institute of Southern Switzerland** · enrollment: 600 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **OTHER:** biological samples collection and analysis

## Key facts

- **NCT ID:** NCT03408964
- **Lead sponsor:** Oncology Institute of Southern Switzerland
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2017-12-15
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2025-11-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03408964

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03408964, "Valid Biomarkers in Blood to Predict the Response to Therapy in Prostate Cancer Patients". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03408964. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*